After about five years working behind the scenes, Arrakis Therapeutics is unveiling that its lead program will aim to treat ...

"Dune"-inspired Arrakis Therapeutics has tested its spice—an RNA-targeting small molecule—in a mouse model of myotonic ...

The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...

ArrakisTx was formed to create RNA-intercepting drugs to fight cancer. Despite some promising data, CEO @michael_gilman says it will shift targets.

Dune: Prophecy viewers think they have worked out the identity of the 'twice-born' figure who is key to the Reckoning.

* ...

The Golden Globes, presented by the Hollywood Foreign Press Association, honor excellence in both film and television.

Prophecy, but fans think they may have already worked out who the 'twice-born' figure is - and it's not Desmond Hart.

Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announces that it has successfully completed an underwritten public offering of 18,000,000 shares of its common stock to the public at a price of ...

Desmond Hart might be the obvious villain, but there are others who are the true villains in the prequel series.

Dispersive Holdings, Inc. (Dispersive), a leader in Stealth Networking which redefines preemptive cybersecurity with zero trust networking, quantum defense, and trusted access across enclaves and ...

Dune: Prophecy's latest episode exposes House Harkonnen's fatal flaw: that even the noblest of members can be corrupted in ...